3M stock faces $5.8 billion PFAS charge as buyback expands

3M has reached a broad resolution of PFAS-related personal injury claims, putting legacy litigation at the center of the investment case while also expanding capital returns. The company announced the agreement on November 3, 2026, alongside a new share repurchase authorization and a quarterly dividend.

3M stock traded at 168.08 euros on Lang & Schwarz at 12:41 CET on Thursday, November 12, 2026, 1.45 percent below the Xetra close of Wednesday, November 11. The intraday move came after the November announcements, but the available trading information does not establish a direct causal link.

Settlement terms and financial effect

According to the published settlement release, 3M will make a pre-tax nominal commitment of 7.35 billion US dollars over nine years through 2034. Its present value is 5.8 billion US dollars. The agreement covers about 99 percent of current personal injury claims inside and outside the AFFF multi-district litigation, with 115,000 to 120,000 plaintiffs eligible to participate.

The payment structure includes 50 million US dollars in 2026, no scheduled payment in 2027 and about 20 percent of payments in the final two years. A 680 million US dollar reserve fund is included in the overall commitment. The agreement also sets out mechanisms for remaining and future claims, with some payments contingent on claimant participation.

3M said it will record a 5.8 billion US dollar pre-tax charge in the fourth quarter of 2026. The charge will be treated as a special item in adjusted results and does not change the company's previously issued 2026 guidance. The agreement is not an admission of liability, and its final implementation depends on participation thresholds and other conditions.

Chief Executive William Brown called the settlement a significant milestone and said it substantially reduces litigation uncertainty. The company linked the agreement to its broader effort to manage legacy PFAS matters, following earlier settlements involving US public water suppliers and the State of New Jersey. 3M has said it ended global PFAS manufacturing by the end of 2025.

Buyback adds shareholder support

3M's board also approved a new authorization to repurchase up to 6.0 billion US dollars of common stock. Combined with 1.5 billion US dollars remaining under the 2025 authorization, the total available capacity rises to 7.5 billion US dollars, with no pre-established closing date. The details were published in the company's November 3 shareholder-return announcement.

The board declared the fourth-quarter 2026 dividend payable on December 11 to shareholders of record at the close of business on November 13. The combination of a long-dated settlement, a large special item and renewed buyback capacity gives investors competing signals: litigation visibility improves, but near-term reported earnings will absorb the charge and cash commitments remain substantial.

In the broader S&P 500 market, investors are likely to focus on how the settlement affects 3M's cash allocation and adjusted earnings over the next reporting periods.

Further details should emerge in 3M's regulatory filings and in the company's next earnings update. More news and analyses on 3M stock